Igor Espinoza‐Delgado

Early epigenetic changes and DNA damage do not predict clinical response in an overlapping schedule of 5-azacytidine and entinostat in patients with myeloid malignancies

Tamer E. Fandy, James G. Herman, Patrick Kerns et al. · Blood · 2009 · 286 citations · Full text

Carboplatin and Paclitaxel in Combination With Either Vorinostat or Placebo for First-Line Therapy of Advanced Non–Small-Cell Lung Cancer

Suresh S. Ramalingam, Michael L. Maitland, Paul Frankel et al. · Journal of Clinical Oncology · 2009 · 267 citations

Purpose Vorinostat, Advanced Nsclc, First-line Therapy +12

Phase I Study of Vorinostat in Combination with Bortezomib for Relapsed and Refractory Multiple Myeloma

Ashraf Badros, Angelika M. Burger, Sunita Philip et al. · Clinical Cancer Research · 2009 · 229 citations · Full text

Phase II Study of Vorinostat for Treatment of Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma and Mantle Cell Lymphoma

Mark Kirschbaum, Paul Frankel, Leslie Popplewell et al. · Journal of Clinical Oncology · 2011 · 211 citations · Full text

Phase II Study of Belinostat in Patients With Recurrent or Refractory Advanced Thymic Epithelial Tumors

Giuseppe Giaccone, Arun Rajan, Arlene Berman et al. · Journal of Clinical Oncology · 2011 · 186 citations · Full text